Historical record - last NADAC effective date: 10/18/2017

Product Information

LOPREEZA 1 MG-0.5 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $2.7686 per EA under NDC 69238125108. Its NADAC has been published 152 times since Dec 10, 2014.

FDA first approved this application on Nov 18, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOPREEZA 1 MG-0.5 MG TABLET

estradiol/norethindrone acetate
$2.7686per EA

Strength

1; .5 mg/1; mg/1

NDC

69238125108

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/18/2017

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020907

FDA Approved

11/18/1998

TE Code

AB

On Market Since

10/1/2014

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen
Progesterone Congeners
Progestin

Price Statistics

The NADAC for LOPREEZA 1 MG-0.5 MG TABLET has been published 152 times since Dec 10, 2014, and over the history we have for it it has declined 22.8%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7686 per EA
All-time high$3.5878 (Dec 10, 2014)
All-time low$2.7611 (Jul 19, 2017)
Median price$3.1640
Average price$3.1602
Largest weekly change-5.3% (Jun 21, 2017)
Weeks tracked152
Tracking sinceDec 10, 2014

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-22.8%

Last surveyed Nov 1, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 61%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of LOPREEZA 1 MG-0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LOPREEZA 1 MG-0.5 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $2.7686 per EA (NDC 69238125108), effective Nov 1, 2017.

How has the price of LOPREEZA 1 MG-0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for LOPREEZA 1 MG-0.5 MG TABLET has declined 22.8%. It has been tracked across 152 weekly CMS publications since Dec 10, 2014.

What are the highest and lowest recorded NADAC prices for LOPREEZA 1 MG-0.5 MG TABLET?

Since Dec 10, 2014, the NADAC for LOPREEZA 1 MG-0.5 MG TABLET has ranged from a low of $2.7611 (Jul 19, 2017) to a high of $3.5878 (Dec 10, 2014), with a median of $3.1640 per EA.

Are there cheaper alternatives to LOPREEZA 1 MG-0.5 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOPREEZA 1 MG-0.5 MG TABLET, is $1.0848 per EA — about 61% below LOPREEZA 1 MG-0.5 MG TABLET.

Who manufactures LOPREEZA 1 MG-0.5 MG TABLET?

LOPREEZA 1 MG-0.5 MG TABLET (NDC 69238125108) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.